M. Masso

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis

Dimitris E. Messinis, G. Silberberg, J. Tegnér, 2019, Proceedings of the National Academy of Sciences.

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

E. Giralt, L. Steinman, I. Pertsovskaya, 2019, Neurotherapeutics.

Signaling networks in MS: A systems-based approach to developing new pharmacological therapies

Ioannis N. Melas, Dimitris E. Messinis, G. Silberberg, 2015, Multiple sclerosis.

Updating of the diagnosis of the community acquired pneumonia

M. Masso, I. Salazar, M. Céspedes, 2011 .

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

E. Giralt, L. Steinman, I. Pertsovskaya, 2019, Neurotherapeutics.

A Phase 1 randomized study on the safety and pharmacokinetics of OCS-05, a neuroprotective disease modifying treatment for Acute Optic Neuritis and Multiple Sclerosis

M. Masso, P. Villoslada, A. Koch, 2023, Scientific Reports.

Double blind clinical trial of bromazepam and alpha methyl dopa in arterial hypertension

M. Masso, H. Perez, 1979 .